Skip to main content
. 2021 Mar 17;64(1):e21. doi: 10.1192/j.eurpsy.2021.13
Grade Recommendation
B In a patient presenting with negative symptoms that are considered to be secondary to treatment-resistant positive symptoms, a trial with clozapine should be considered.